| | | 54704 | | 17.08.1999 | | Sandoz Pharmaceuticals AG | | 07.03.2005 | | | | | | | | | | | 07.08.60. | | | | 07.08.60. | | IP |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | Estalis 50/140 | transdermale Pflaster | Transdermal patch (Estradiol 0.6 mg, Norethisterone Acetate 2.7 mg) | G03FA01 | CI | | 02 | Estalis 50/250 | transdermale Pflaster | Transdermal patch (Estradiol 0.496 mg, Norethisterone Acetate 4.8 mg) | G03FA01 | CI |
|
|
